\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ lateral\\ aspect\\ of\\ the\\ proximal\\ calf\\ and\\ left\\ knee\\ were\\ warm\\ to\\ touch\\ with\\ tenderness\\ elicited\\ at\\ the\\ tibial\\ tuberosity\\ and\\ pain\\ within\\ the\\ joint\\ space\\ upon\\ manipulation\\ and\\ ballottement\\ of\\ the\\ patella\\.\\ there\\ was\\ compromised\\ range\\ of\\ motion\\ of\\ the\\ left\\ knee\\,\\ both\\ passive\\ and\\ active\\,\\ secondary\\ to\\ pain\\ and\\ guarding\\.\\ \\ all\\ other\\ aspects\\ of\\ the\\ exam\\ were\\ unremarkable\\.\ \(0\)\
\-\ intraoperative\\ frozen\\ section\\ analysis\\ of\\ bone\\ biopsy\\ obtained\\ under\\ fluoroscopic\\ guidance\\ was\\ concerning\\ for\\ malignant\\ small\\ round\\ cell\\ tumor\\.\\ \\ the\\ formal\\ pathology\\ report\\ listed\\ ewing\\ sarcoma\\ as\\ the\\ most\\ likely\\ diagnosis\\.\\ immunostains\\ revealed\\ strong\\ membranous\\ cd99\\ staining\\ and\\ were\\ negative\\ for\\ myogenin\\,\\ s\\-100\\,\\ cytokeratin\\,\\ cd45\\,\\ tdt\\,\\ cd20\\,\\ and\\ cd3\\.\\ \\ chromosome\\ analysis\\ a\\ normal\\ female\\ karyotype\\ of\\ 46\\,xx\\.\\ no\\ clonal\\ abnormal\\ cells\\ were\\ identified\\.\ \(0\)\
\-\ treatment\\:\\ the\\ patient\\ was\\ enrolled\\ in\\ the\\ children\\â\\€\\™s\\ oncology\\ group\\ metastatic\\ ewings\\ protocol\\ with\\ randomization\\ between\\ autologous\\ transplant\\ and\\ standard\\ therapy\\,\\ or\\ standard\\ therapy\\ alone\\ with\\ surgery\\,\\ radiation\\,\\ and\\ chemotherapy\\.\\ she\\ was\\ admitted\\ to\\ the\\ inpatient\\ oncology\\ unit\\ and\\ began\\ anti\\-neoplastic\\ therapy\\ per\\ protocol\\ aews0331\\ with\\ vincristine\\,\\ ifosfamide\\ \\+\\ mesna\\,\\ doxyrubicin\\,\\ and\\ etoposide\\ \\(vide\\)\\.\ \(0\)\
\-\ follow\\-up\\:\\ the\\ patient\\ completed\\ six\\ rounds\\ of\\ cyctoreductive\\ therapy\\ per\\ aews0331\\ vai\\ protocol\\.\\ \\ no\\ pulmonary\\ nodule\\ was\\ detected\\ on\\ follow\\-up\\ ct\\ after\\ the\\ second\\ vide\\ cycle\\.\\ she\\ is\\ set\\ to\\ undergo\\ limb\\ reconstructive\\ surgery\\ for\\ local\\ control\\ upon\\ arrival\\ of\\ her\\ custom\\ prosthetic\\ implant\\ from\\ europe\\.\\ high\\ dose\\ chemotherapy\\ and\\ autologous\\ stem\\ cell\\ rescue\\ is\\ a\\ therapy\\ option\\ which\\ may\\ benefit\\ her\\ in\\ the\\ future\\ as\\ the\\ patient\\ underwent\\ stem\\ cell\\ harvest\\ after\\ her\\ second\\ cycle\\ of\\ chemotherapy\\.\ \(0\)\
\-\ xr\\ knee\\:\\ lucent\\ poorly\\ defined\\ lesion\\ involving\\ the\\ proximal\\ tibial\\ diaphysis\\,\\ with\\ a\\ moth\\-eaten\\ appearance\\ and\\ irregular\\ zone\\ of\\ transition\\ proximally\\ and\\ thickening\\ of\\ the\\ cortex\\ of\\ the\\ lateral\\ tibial\\ diaphysis\\.\\ there\\ is\\ also\\ periostial\\ reaction\\ extending\\ superior\\ to\\ this\\ along\\ the\\ lateral\\ aspect\\ of\\ the\\ proximal\\ tibial\\ metaphysis\\,\\ and\\ at\\ the\\ inferior\\ aspect\\ of\\ the\\ lesion\\,\\ there\\ is\\ an\\ apparent\\ codman\\â\\€\\™s\\ triangle\\.\\ there\\ is\\ also\\ bowing\\ deformity\\ of\\ the\\ proximal\\ tibia\\,\\ apex\\ medial\\.\\ there\\ is\\ suggestion\\ of\\ very\\ subtle\\ periosteal\\ reaction\\ of\\ the\\ fibular\\ diaphysis\\.\ \(0\)\
\-\ cxr\\:\\ increased\\ pulmonary\\ markings\\ with\\ no\\ focal\\ infiltrates\\.\\ no\\ clear\\ evidence\\ of\\ metastases\\ or\\ malignancy\\ is\\ seen\\.\\ \ \(0\)\
\-\ mri\\ \\(left\\ tib\\/fib\\)\\:\\ large\\ aggressive\\ appearing\\ lesion\\ involving\\ the\\ proximal\\ and\\ mid\\ tibia\\,\\ its\\ periosteum\\,\\ and\\ the\\ surrounding\\ soft\\ tissues\\ including\\ adjacent\\ musculature\\,\\ with\\ probable\\ involvement\\ of\\ the\\ proximal\\ fibular\\ cortex\\.\\ soft\\ tissue\\ abnormalities\\ extend\\ down\\ to\\ the\\ level\\ of\\ the\\ distal\\ tibial\\ metaphysis\\.\\ the\\ soft\\ tissue\\ component\\ of\\ the\\ tumor\\ measures\\ 4\\.4\\ cm\\ transverse\\ x\\ 4\\.8\\ cm\\ ap\\ x\\ 8\\.1cm\\ craniocaudal\\.\\ there\\ is\\ disruption\\ and\\ partial\\ destruction\\ of\\ the\\ proximal\\ tibial\\ cortex\\ adjacent\\ to\\ the\\ soft\\ tissue\\ component\\ described\\ above\\.\ \(0\)\
\-\ nuc\\ bone\\ scan\\:\\ abnormal\\ tracer\\ accumulation\\ is\\ present\\ in\\ the\\ left\\ tibia\\ from\\ the\\ proximal\\ metaphysis\\ to\\ the\\ mid\\ diaphysis\\.\\ \\ \\ \ \(0\)\
\-\ ct\\ chest\\/abd\\/pelvis\\:\\ nine\\ millimeter\\ nodular\\ density\\ in\\ the\\ left\\ lung\\ apex\\ with\\ a\\ second\\ three\\ millimeter\\ density\\ in\\ the\\ right\\ lower\\ lobe\\.\\ several\\ right\\ lower\\ quadrant\\ mesenteric\\ masses\\ measuring\\ up\\ to\\ fifteen\\ millimeters\\ are\\ consistent\\ with\\ mesenteric\\ lymph\\ nodes\\.\ \(0\)\
\-\ ewing\\ sarcoma\\ of\\ the\\ tibia\ \(0\)\
\-\ 1\\.\\ bone\\ tumor\\ \\(osteogenc\\ sarcoma\\ vs\\.\\ ewing\\ sarcoma\\)\ \(0\)\
\-\ 2\\.\\ chondrosarcoma\ \(0\)\
\-\ 3\\.\\ osteomyelitis\ \(0\)\
\-\ 4\\.\\ leukemia\\/lymphoma\ \(0\)\
\-\ 5\\.\\ septic\\ joint\ \(0\)\
\-\ 6\\.\\ soft\\ tissue\\ sarcoma\ \(0\)\
\-\ 7\\.\\ myositis\\/muscular\\ infection\ \(0\)\
\-\ 8\\.\\ knee\\ synovitis\ \(0\)\
\-\ a\\ nine\\-year\\-old\\ girl\\ with\\ no\\ significant\\ past\\ medical\\ history\\ presented\\ with\\ localized\\ left\\ lateral\\ calf\\ pain\\ of\\ one\\ month\\ duration\\.\\ there\\ was\\ increased\\ pain\\ with\\ mild\\ swelling\\,\\ warmth\\ to\\ touch\\,\\ and\\ limping\\ noted\\ three\\ days\\ prior\\ to\\ presentation\\.\\ \\ two\\ days\\ later\\ progression\\ of\\ the\\ patient\\*s\\ calf\\ pain\\ with\\ refusal\\ to\\ bear\\ weight\\ and\\ a\\ concomitant\\ low\\-grade\\ fever\\ prompted\\ a\\ visit\\ to\\ the\\ emergency\\ department\\ at\\ an\\ outside\\ facility\\ where\\ a\\ radiograph\\ of\\ the\\ knee\\ showed\\ a\\ bony\\ irregularity\\ with\\ soft\\ tissue\\ swelling\\ to\\ the\\ left\\ tibia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tibial\\:\\ 0\\.03423107491483453\ \(0\)\
\-\ proximal\\:\\ 0\\.029659458748057976\ \(0\)\
\-\ tibia\\:\\ 0\\.028361049824745264\ \(0\)\
\-\ sarcoma\\:\\ 0\\.027491930129120247\ \(0\)\
\-\ diaphysis\\:\\ 0\\.026566535946765266\ \(0\)\
\-\ aews0331\\:\\ 0\\.025478376947880053\ \(0\)\
\-\ vide\\:\\ 0\\.025478376947880053\ \(0\)\
\-\ millimeter\\:\\ 0\\.023475061397128766\ \(0\)\
\-\ calf\\:\\ 0\\.022682078694409195\ \(0\)\
\-\ ewing\\:\\ 0\\.022682078694409195\ \(0\)\
\-\ knee\\:\\ 0\\.022387938746822808\ \(0\)\
\-\ protocol\\:\\ 0\\.01992490196007395\ \(0\)\
\-\ metaphysis\\:\\ 0\\.018429928753606915\ \(0\)\
\-\ autologous\\:\\ 0\\.018296565821325137\ \(0\)\
\-\ soft\\:\\ 0\\.01804271760688049\ \(0\)\
\-\ therapy\\:\\ 0\\.01650752020405067\ \(0\)\
\-\ fibular\\:\\ 0\\.01629325027057385\ \(0\)\
\-\ cycle\\:\\ 0\\.016175267627451726\ \(0\)\
\-\ cortex\\:\\ 0\\.01585171874892472\ \(0\)\
\-\ oncology\\:\\ 0\\.015746308075086774\ \(0\)\
\-\ stem\\:\\ 0\\.014675863600240258\ \(0\)\
\-\ tissue\\:\\ 0\\.014634546159339549\ \(0\)\
\-\ second\\:\\ 0\\.014228882667221\ \(0\)\
\-\ touch\\:\\ 0\\.013326086140391711\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.013278666698587564\ \(0\)\
\-\ there\\:\\ 0\\.012864174704125608\ \(0\)\
\-\ ballottement\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ myogenin\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ tdt\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ randomization\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ cyctoreductive\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ vai\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ harvest\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ periostial\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ codman\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ 8\\.1cm\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ osteogenc\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ myositis\\/muscular\\:\\ 0\\.012739188473940026\ \(0\)\
\-\ apex\\:\\ 0\\.012707161318410116\ \(0\)\
\-\ standard\\:\\ 0\\.012638344414671045\ \(0\)\
\-\ analysis\\:\\ 0\\.012571128050034434\ \(0\)\
\-\ cd99\\:\\ 0\\.011737530698564383\ \(0\)\
\-\ cd45\\:\\ 0\\.011737530698564383\ \(0\)\
\-\ clonal\\:\\ 0\\.011737530698564383\ \(0\)\
\-\ anti\\-neoplastic\\:\\ 0\\.011737530698564383\ \(0\)\
\-\ ifosfamide\\:\\ 0\\.011737530698564383\ \(0\)\
\-\ aspect\\:\\ 0\\.011637103762211085\ \(0\)\
\-\ \\:\\:\\ 0\\.011433415768691698\ \(0\)\
\-\ mesenteric\\:\\ 0\\.011388211273888284\ \(0\)\
\-\ component\\:\\ 0\\.011279952422631348\ \(0\)\
\-\ reaction\\:\\ 0\\.011216891592011\ \(0\)\
\-\ were\\:\\ 0\\.011215527957745209\ \(0\)\
\-\ immunostains\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ cd3\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ xx\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ mesna\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ doxyrubicin\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ millimeters\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ nine\\-year\\-old\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ refusal\\:\\ 0\\.011151598461413855\ \(0\)\
\-\ her\\:\\ 0\\.01113906788360521\ \(0\)\
\-\ per\\:\\ 0\\.010810244533909453\ \(0\)\
\-\ s\\-100\\:\\ 0\\.01073587292318874\ \(0\)\
\-\ custom\\:\\ 0\\.01073587292318874\ \(0\)\
\-\ triangle\\:\\ 0\\.01073587292318874\ \(0\)\
\-\ tib\\/fib\\:\\ 0\\.01073587292318874\ \(0\)\
\-\ nuc\\:\\ 0\\.01073587292318874\ \(0\)\
\-\ chest\\/abd\\/pelvis\\:\\ 0\\.01073587292318874\ \(0\)\
\-\ lateral\\:\\ 0\\.010674381766615898\ \(0\)\
\-\ s\\:\\ 0\\.010624715319860926\ \(0\)\
\-\ enrolled\\:\\ 0\\.010413411143832945\ \(0\)\
\-\ rescue\\:\\ 0\\.010413411143832945\ \(0\)\
\-\ moth\\-eaten\\:\\ 0\\.010413411143832945\ \(0\)\
\-\ fifteen\\:\\ 0\\.010413411143832945\ \(0\)\
\-\ leukemia\\/lymphoma\\:\\ 0\\.010413411143832945\ \(0\)\
\-\ mid\\:\\ 0\\.010328819100886866\ \(0\)\
\-\ formal\\:\\ 0\\.010149940686038212\ \(0\)\
\-\ karyotype\\:\\ 0\\.010149940686038212\ \(0\)\
\-\ rounds\\:\\ 0\\.010149940686038212\ \(0\)\
\-\ upon\\:\\ 0\\.01009395504285575\ \(0\)\
\-\ cell\\:\\ 0\\.01000682389413939\ \(0\)\
\-\ cytokeratin\\:\\ 0\\.009927179588021943\ \(0\)\
\-\ cd20\\:\\ 0\\.009927179588021943\ \(0\)\
\-\ europe\\:\\ 0\\.009927179588021943\ \(0\)\
\-\ limping\\:\\ 0\\.009927179588021943\ \(0\)\
\-\ etoposide\\:\\ 0\\.009734215147813094\ \(0\)\
\-\ left\\:\\ 0\\.009671585093801161\ \(0\)\
\-\ 4\\.4\\:\\ 0\\.009564008448887685\ \(0\)\
\-\ prosthetic\\:\\ 0\\.009411753368457301\ \(0\)\
\-\ \\,\\:\\ 0\\.009388788399443493\ \(0\)\
\-\ frozen\\:\\ 0\\.009274021894751629\ \(0\)\
\-\ membranous\\:\\ 0\\.009274021894751629\ \(0\)\
\-\ bone\\:\\ 0\\.009205641682629493\ \(0\)\
\-\ chromosome\\:\\ 0\\.009148282910662569\ \(0\)\
\-\ xr\\:\\ 0\\.009148282910662569\ \(0\)\
\-\ reconstructive\\:\\ 0\\.009032614257955146\ \(0\)\
\-\ 4\\.8\\:\\ 0\\.009032614257955146\ \(0\)\
\-\ the\\:\\ 0\\.008790416946473315\ \(0\)\
\-\ ewings\\:\\ 0\\.00873255737243745\ \(0\)\
\-\ involving\\:\\ 0\\.008665916947986397\ \(0\)\
\-\ to\\:\\ 0\\.008640106240176023\ \(0\)\
\-\ tumor\\:\\ 0\\.008636845238197157\ \(0\)\
\-\ was\\:\\ 0\\.008568880250407689\ \(0\)\
\-\ compromised\\:\\ 0\\.008562350673512043\ \(0\)\
\-\ tuberosity\\:\\ 0\\.008484218850867135\ \(0\)\
\-\ nine\\:\\ 0\\.008484218850867135\ \(0\)\
\-\ vincristine\\:\\ 0\\.008339589575495772\ \(0\)\
\-\ periosteum\\:\\ 0\\.008339589575495772\ \(0\)\
\-\ three\\:\\ 0\\.00832550355013558\ \(0\)\
\-\ set\\:\\ 0\\.008272364119375986\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.008272364119375986\ \(0\)\
\-\ swelling\\:\\ 0\\.008227777063529285\ \(0\)\
\-\ staining\\:\\ 0\\.008208127468262064\ \(0\)\
\-\ x\\:\\ 0\\.008147590564588084\ \(0\)\
\-\ intraoperative\\:\\ 0\\.008146625135286925\ \(0\)\
\-\ density\\:\\ 0\\.008126102187456529\ \(0\)\
\-\ listed\\:\\ 0\\.008087633813725863\ \(0\)\
\-\ tracer\\:\\ 0\\.008087633813725863\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.008034788992606191\ \(0\)\
\-\ concomitant\\:\\ 0\\.008030956482579503\ \(0\)\
\-\ joint\\:\\ 0\\.007986789754456882\ \(0\)\
\-\ arrival\\:\\ 0\\.007976418436361515\ \(0\)\
\-\ warmth\\:\\ 0\\.007976418436361515\ \(0\)\
\-\ guidance\\:\\ 0\\.007923864037270656\ \(0\)\
\-\ proximally\\:\\ 0\\.007923864037270656\ \(0\)\
\-\ bowing\\:\\ 0\\.007923864037270656\ \(0\)\
\-\ warm\\:\\ 0\\.007873154037543387\ \(0\)\
\-\ elicited\\:\\ 0\\.00782416335593113\ \(0\)\
\-\ adjacent\\:\\ 0\\.007808775272064356\ \(0\)\
\-\ implant\\:\\ 0\\.007776779218903688\ \(0\)\
\-\ infiltrates\\:\\ 0\\.007686431882225459\ \(0\)\
\-\ bear\\:\\ 0\\.007686431882225459\ \(0\)\
\-\ prompted\\:\\ 0\\.007686431882225459\ \(0\)\
\-\ musculature\\:\\ 0\\.0076014022579148615\ \(0\)\
\-\ synovitis\\:\\ 0\\.0076014022579148615\ \(0\)\
\-\ days\\:\\ 0\\.0075695788906704545\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.007560692898136399\ \(0\)\
\-\ lesion\\:\\ 0\\.007545759650290988\ \(0\)\
\-\ pain\\:\\ 0\\.00754052144169606\ \(0\)\
\-\ unit\\:\\ 0\\.007482561075491492\ \(0\)\
\-\ suggestion\\:\\ 0\\.007482561075491492\ \(0\)\
\-\ inpatient\\:\\ 0\\.007445024245428976\ \(0\)\
\-\ passive\\:\\ 0\\.0074084378177060135\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.00738158017238571\ \(0\)\
\-\ benefit\\:\\ 0\\.007372754851534957\ \(0\)\
\-\ manipulation\\:\\ 0\\.007337931800120129\ \(0\)\
\-\ is\\:\\ 0\\.00731303035471464\ \(0\)\
\-\ patella\\:\\ 0\\.007238231118780605\ \(0\)\
\-\ pulmonary\\:\\ 0\\.007215463324335443\ \(0\)\
\-\ transition\\:\\ 0\\.00720646969288642\ \(0\)\
\-\ strong\\:\\ 0\\.007175391361642254\ \(0\)\
\-\ aspects\\:\\ 0\\.00711517070210386\ \(0\)\
\-\ completed\\:\\ 0\\.00711517070210386\ \(0\)\
\-\ probable\\:\\ 0\\.00711517070210386\ \(0\)\
\-\ visit\\:\\ 0\\.00708597603835022\ \(0\)\
\-\ abnormal\\:\\ 0\\.007043619191661593\ \(0\)\
\-\ limb\\:\\ 0\\.006974760660985872\ \(0\)\
\-\ she\\:\\ 0\\.006932907923277954\ \(0\)\
\-\ option\\:\\ 0\\.006896628838340965\ \(0\)\
\-\ 8\\.\\:\\ 0\\.006896628838340965\ \(0\)\
\-\ \\*\\:\\ 0\\.0068714962621677445\ \(0\)\
\-\ future\\:\\ 0\\.006846793323787252\ \(0\)\
\-\ markings\\:\\ 0\\.006846793323787252\ \(0\)\
\-\ transplant\\:\\ 0\\.006822505580555488\ \(0\)\
\-\ fluoroscopic\\:\\ 0\\.006751999562969603\ \(0\)\
\-\ facility\\:\\ 0\\.006751999562969603\ \(0\)\
\-\ guarding\\:\\ 0\\.006684774106849815\ \(0\)\
\-\ alone\\:\\ 0\\.006684774106849815\ \(0\)\
\-\ cm\\:\\ 0\\.00662415062952886\ \(0\)\
\-\ section\\:\\ 0\\.006620537455735894\ \(0\)\
\-\ lucent\\:\\ 0\\.006599744482539218\ \(0\)\
\-\ irregularity\\:\\ 0\\.006599744482539218\ \(0\)\
\-\ accumulation\\:\\ 0\\.0065792464550941945\ \(0\)\
\-\ 7\\.\\:\\ 0\\.0065792464550941945\ \(0\)\
\-\ zone\\:\\ 0\\.006559035122760755\ \(0\)\
\-\ 46\\:\\ 0\\.006539102576326745\ \(0\)\
\-\ duration\\:\\ 0\\.006539102576326745\ \(0\)\
\-\ detected\\:\\ 0\\.006519441229425329\ \(0\)\
\-\ concerning\\:\\ 0\\.0064809033001158485\ \(0\)\
\-\ septic\\:\\ 0\\.0064809033001158485\ \(0\)\
\-\ dose\\:\\ 0\\.006462013008833546\ \(0\)\
\-\ group\\:\\ 0\\.00642495747326514\ \(0\)\
\-\ \\+\\:\\ 0\\.006371097076159313\ \(0\)\
\-\ undergo\\:\\ 0\\.006269048568624699\ \(0\)\
\-\ began\\:\\ 0\\.006252719731552541\ \(0\)\
\-\ no\\:\\ 0\\.006217082013755795\ \(0\)\
\-\ extend\\:\\ 0\\.006189189206377517\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.006173733586266611\ \(0\)\
\-\ progression\\:\\ 0\\.006143309584535639\ \(0\)\
\-\ destruction\\:\\ 0\\.00609884186969929\ \(0\)\
\-\ six\\:\\ 0\\.006069939172146298\ \(0\)\
\-\ increased\\:\\ 0\\.006041863531212877\ \(0\)\
\-\ aggressive\\:\\ 0\\.006041603230833616\ \(0\)\
\-\ poorly\\:\\ 0\\.006027640931828216\ \(0\)\
\-\ disruption\\:\\ 0\\.006013812245388692\ \(0\)\
\-\ localized\\:\\ 0\\.006013812245388692\ \(0\)\
\-\ 6\\.\\:\\ 0\\.006000114638517964\ \(0\)\
\-\ surgery\\:\\ 0\\.00599710712242854\ \(0\)\
\-\ periosteal\\:\\ 0\\.005857434232902806\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.005738918117785993\ \(0\)\
\-\ local\\:\\ 0\\.005672209964949052\ \(0\)\
\-\ subtle\\:\\ 0\\.005672209964949052\ \(0\)\
\-\ control\\:\\ 0\\.00562938944817684\ \(0\)\
\-\ nodes\\:\\ 0\\.005577588679718551\ \(0\)\
\-\ lower\\:\\ 0\\.005554514651340643\ \(0\)\
\-\ department\\:\\ 0\\.0055374448009511005\ \(0\)\
\-\ report\\:\\ 0\\.00552758068957769\ \(0\)\
\-\ appearing\\:\\ 0\\.005488784085479152\ \(0\)\
\-\ apparent\\:\\ 0\\.005460355233457903\ \(0\)\
\-\ under\\:\\ 0\\.005396118582343981\ \(0\)\
\-\ round\\:\\ 0\\.005334616249368843\ \(0\)\
\-\ children\\:\\ 0\\.005334616249368843\ \(0\)\
\-\ admitted\\:\\ 0\\.005334616249368843\ \(0\)\
\-\ 5\\.\\:\\ 0\\.0053260400419702664\ \(0\)\
\-\ deformity\\:\\ 0\\.005317514431959879\ \(0\)\
\-\ down\\:\\ 0\\.005300612640394574\ \(0\)\
\-\ measures\\:\\ 0\\.005283906249641574\ \(0\)\
\-\ metastases\\:\\ 0\\.005275624927807781\ \(0\)\
\-\ described\\:\\ 0\\.0052592033112610825\ \(0\)\
\-\ cxr\\:\\ 0\\.0052110292935333485\ \(0\)\
\-\ defined\\:\\ 0\\.005203154142135133\ \(0\)\
\-\ and\\:\\ 0\\.0052025724200063135\ \(0\)\
\-\ nodular\\:\\ 0\\.005179782958254207\ \(0\)\
\-\ outside\\:\\ 0\\.005179782958254207\ \(0\)\
\-\ a\\:\\ 0\\.005158089908045393\ \(0\)\
\-\ after\\:\\ 0\\.0051098300653445155\ \(0\)\
\-\ nodule\\:\\ 0\\.005089904045147408\ \(0\)\
\-\ tissues\\:\\ 0\\.0050682813967706545\ \(0\)\
\-\ pathology\\:\\ 0\\.005054043974165147\ \(0\)\
\-\ where\\:\\ 0\\.005039945455457972\ \(0\)\
\-\ at\\:\\ 0\\.0050192044197903156\ \(0\)\
\-\ lymph\\:\\ 0\\.0049848878741974665\ \(0\)\
\-\ range\\:\\ 0\\.004971445110234585\ \(0\)\
\-\ motion\\:\\ 0\\.004964770332985605\ \(0\)\
\-\ cells\\:\\ 0\\.004951512563800574\ \(0\)\
\-\ transverse\\:\\ 0\\.004951512563800574\ \(0\)\
\-\ patient\\:\\ 0\\.0049513984446033985\ \(0\)\
\-\ partial\\:\\ 0\\.004938375321457724\ \(0\)\
\-\ measuring\\:\\ 0\\.004938375321457724\ \(0\)\
\-\ bony\\:\\ 0\\.004938375321457724\ \(0\)\
\-\ irregular\\:\\ 0\\.0049253564342577735\ \(0\)\
\-\ also\\:\\ 0\\.0048688427562721135\ \(0\)\
\-\ vs\\:\\ 0\\.004861965275145661\ \(0\)\
\-\ 4\\.\\:\\ 0\\.004861965275145661\ \(0\)\
\-\ malignancy\\:\\ 0\\.004771805892776757\ \(0\)\
\-\ active\\:\\ 0\\.004714680403244046\ \(0\)\
\-\ emergency\\:\\ 0\\.004675995083786526\ \(0\)\
\-\ its\\:\\ 0\\.004659727519444568\ \(0\)\
\-\ clear\\:\\ 0\\.004565789903391106\ \(0\)\
\-\ of\\:\\ 0\\.004545668528245213\ \(0\)\
\-\ abnormalities\\:\\ 0\\.004535787025575457\ \(0\)\
\-\ involvement\\:\\ 0\\.0045259229142020465\ \(0\)\
\-\ above\\:\\ 0\\.0045259229142020465\ \(0\)\
\-\ ap\\:\\ 0\\.0045161256786740425\ \(0\)\
\-\ very\\:\\ 0\\.004482349159620129\ \(0\)\
\-\ malignant\\:\\ 0\\.004463396931183961\ \(0\)\
\-\ including\\:\\ 0\\.00445869745808226\ \(0\)\
\-\ later\\:\\ 0\\.00445869745808226\ \(0\)\
\-\ weight\\:\\ 0\\.004426222232862521\ \(0\)\
\-\ identified\\:\\ 0\\.004412524625991794\ \(0\)\
\-\ obtained\\:\\ 0\\.004389979914369713\ \(0\)\
\-\ biopsy\\:\\ 0\\.004381059597740983\ \(0\)\
\-\ quadrant\\:\\ 0\\.004345918979748634\ \(0\)\
\-\ girl\\:\\ 0\\.004341585882933234\ \(0\)\
\-\ presentation\\:\\ 0\\.004253469124987113\ \(0\)\
\-\ underwent\\:\\ 0\\.004237277507916502\ \(0\)\
\-\ 3\\.\\:\\ 0\\.004225251751648449\ \(0\)\
\-\ inferior\\:\\ 0\\.004189763527975524\ \(0\)\
\-\ thickening\\:\\ 0\\.004185873655626231\ \(0\)\
\-\ fever\\:\\ 0\\.004178125182878563\ \(0\)\
\-\ masses\\:\\ 0\\.004174266471092611\ \(0\)\
\-\ extending\\:\\ 0\\.004151328105259822\ \(0\)\
\-\ unremarkable\\:\\ 0\\.004088246269771763\ \(0\)\
\-\ space\\:\\ 0\\.004084619952422882\ \(0\)\
\-\ along\\:\\ 0\\.004081002712223289\ \(0\)\
\-\ surrounding\\:\\ 0\\.00405948737624966\ \(0\)\
\-\ radiation\\:\\ 0\\.004052386198789503\ \(0\)\
\-\ showed\\:\\ 0\\.004048848653068925\ \(0\)\
\-\ several\\:\\ 0\\.003969787334858942\ \(0\)\
\-\ revealed\\:\\ 0\\.003963112557609961\ \(0\)\
\-\ medial\\:\\ 0\\.00394985478842493\ \(0\)\
\-\ superior\\:\\ 0\\.003943271238517617\ \(0\)\
\-\ radiograph\\:\\ 0\\.0039334518120250905\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0039269424014454594\ \(0\)\
\-\ past\\:\\ 0\\.00392369865888213\ \(0\)\
\-\ between\\:\\ 0\\.003914010890497462\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0038572097778867063\ \(0\)\
\-\ medical\\:\\ 0\\.003799580635933532\ \(0\)\
\-\ tenderness\\:\\ 0\\.003755653645782707\ \(0\)\
\-\ as\\:\\ 0\\.0037357731384223343\ \(0\)\
\-\ month\\:\\ 0\\.0037046452901742907\ \(0\)\
\-\ negative\\:\\ 0\\.0036880349152816102\ \(0\)\
\-\ from\\:\\ 0\\.003660218824145122\ \(0\)\
\-\ infection\\:\\ 0\\.0035896193266948075\ \(0\)\
\-\ lung\\:\\ 0\\.003576819537917263\ \(0\)\
\-\ level\\:\\ 0\\.003559088190241231\ \(0\)\
\-\ two\\:\\ 0\\.0035366058347052103\ \(0\)\
\-\ appearance\\:\\ 0\\.0035316569027957247\ \(0\)\
\-\ focal\\:\\ 0\\.003526724861471679\ \(0\)\
\-\ all\\:\\ 0\\.003492664002068339\ \(0\)\
\-\ likely\\:\\ 0\\.003483077985456151\ \(0\)\
\-\ scan\\:\\ 0\\.003457039682706616\ \(0\)\
\-\ ct\\:\\ 0\\.0034546348363931876\ \(0\)\
\-\ secondary\\:\\ 0\\.0034523554429318026\ \(0\)\
\-\ an\\:\\ 0\\.003415216370765115\ \(0\)\
\-\ high\\:\\ 0\\.0033794018223653405\ \(0\)\
\-\ presented\\:\\ 0\\.003366123750032383\ \(0\)\
\-\ distal\\:\\ 0\\.0033573390013670905\ \(0\)\
\-\ one\\:\\ 0\\.003346432634841971\ \(0\)\
\-\ lobe\\:\\ 0\\.0033227244912189795\ \(0\)\
\-\ up\\:\\ 0\\.003320588368575467\ \(0\)\
\-\ significant\\:\\ 0\\.003320588368575467\ \(0\)\
\-\ mild\\:\\ 0\\.0032518113496114694\ \(0\)\
\-\ evidence\\:\\ 0\\.0032376337909925976\ \(0\)\
\-\ prior\\:\\ 0\\.0031706831968242245\ \(0\)\
\-\ for\\:\\ 0\\.003160873476774776\ \(0\)\
\-\ both\\:\\ 0\\.0031534681946331234\ \(0\)\
\-\ \\(\\:\\ 0\\.0031316259808259845\ \(0\)\
\-\ metastatic\\:\\ 0\\.003108539600601286\ \(0\)\
\-\ \\)\\:\\ 0\\.0030933714976010334\ \(0\)\
\-\ in\\:\\ 0\\.0030447776744238074\ \(0\)\
\-\ consistent\\:\\ 0\\.0030278876717213916\ \(0\)\
\-\ noted\\:\\ 0\\.00292690923186791\ \(0\)\
\-\ or\\:\\ 0\\.0028945744189702526\ \(0\)\
\-\ most\\:\\ 0\\.0028509178348671616\ \(0\)\
\-\ other\\:\\ 0\\.002846298480783885\ \(0\)\
\-\ small\\:\\ 0\\.002844761971649015\ \(0\)\
\-\ mri\\:\\ 0\\.0028371038365818204\ \(0\)\
\-\ diagnosis\\:\\ 0\\.002835577067601763\ \(0\)\
\-\ present\\:\\ 0\\.0027890299912307526\ \(0\)\
\-\ exam\\:\\ 0\\.002712765809175633\ \(0\)\
\-\ may\\:\\ 0\\.0027085670070782133\ \(0\)\
\-\ large\\:\\ 0\\.002700205826345491\ \(0\)\
\-\ right\\:\\ 0\\.002605871991648603\ \(0\)\
\-\ female\\:\\ 0\\.002538670912496869\ \(0\)\
\-\ treatment\\:\\ 0\\.0024994464734116864\ \(0\)\
\-\ seen\\:\\ 0\\.0024402133165718066\ \(0\)\
\-\ with\\:\\ 0\\.0023671365104890986\ \(0\)\
\-\ within\\:\\ 0\\.0023556812259914474\ \(0\)\
\-\ which\\:\\ 0\\.002305122235899637\ \(0\)\
\-\ normal\\:\\ 0\\.001935856148264597\ \(0\)\
\-\ history\\:\\ 0\\.001705512337726999\ \(0\)\
\-\ are\\:\\ 0\\.0016833437464300602\ \(0\)\
\-\ \\.\\:\\ 0\\.0015902971373088649\ \(0\)\
\-\ this\\:\\ 0\\.0013889266088354523\ \(0\)\
\-\ on\\:\\ 0\\.0010460852779847227\ \(0\)\
